Nazareth (Belgium)/Rotterdam (The Netherlands), 24 February 2022
Invitation Fagron Capital Markets Day 2022
Fagron, a leading global company active in pharmaceutical compounding, will organize its Capital Markets Day on Tuesday 15 March 2022. The event will take place at the Fagron Netherlands premises located at Venkelbaan 101, Capelle aan den IJssel, the Netherlands. Participants will have the opportunity to attend in person or via a live video webcast.
Registration for the video webcast is available via the link below:
https://investors.fagron.com/fagron-cmd-2022-webcast/
For those wishing to attend in person, we will be able to welcome a maximum of 50 persons in our offices. To register your interest in attending in person, please email investors@fagron.com no later than 8 March 2022. As the number of guests that we can accommodate is limited, registration will be on a ‘first-come, first-served’ basis.
Program:
Welcome and sandwiches: 1:30PM CET
Start presentation: 2PM CET
End presentation and drinks: approx. 5PM CET
A detailed agenda for the day will be made available on the Fagron website on the day.
Further information
Karen Berg
Global Investor Relations Manager
Tel. +31 6 53 44 91 99
karen.berg@fagron.com
About Fagron
Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics and patients in 35 countries around the world.
Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.